Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-19 Sale | 2023-04-20 4:12 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 1,290 | $1.272 | $1,641 | 83,663 (Direct) | View |
| 2023-01-18 Sale | 2023-01-19 4:58 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 6,347 | $6.996 | $44,404 | 64,453 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-14 Option Award | 2024-03-15 4:33 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 250,000 | $0 | 333,663 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:23 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 107,400 | $0 | 171,853 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:47 pm | N/A 2032-06-07 | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 52,000 | $0 | 52,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-28 5:07 pm | N/A 2032-01-27 | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 171,250 | $0 | 171,250 (Direct) | View |
| 2021-11-17 Disposition | 2021-11-19 1:27 pm | N/A 2031-05-03 | Trillium Therapeutics Inc. | TRIL | Looker Benjamin General Counsel | 190,000 | $0 | 0 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 4:17 pm | N/A 2031-05-03 | Trillium Therapeutics Inc. | TRIL | Looker Benjamin General Counsel | 190,000 | $0 | 190,000 (Direct) | View |